Innovate Corp

Innovate Corp(VATE)股票分析

$4.970

-0.421 (-8.47%)收盤時

Loading chart…
最高
5.520
開盤
5.270
成交量加權均價
5.15
成交量
83.53K
市值
88.63M
最低
4.970
成交金額
430.48K
企業價值/稅息折舊攤銷前利潤(TTM)
0.00

Innovate Corp. is a diversified holding company. The Company has a portfolio of subsidiaries in a variety of operating segments. Its segments include Infrastructure (DBMG), Life Sciences (Pansend), and Spectrum. The DBMG segment consists of DBM Global Inc., which is a fully integrated construction company offering both construction and professional services primarily through its core subsidiaries. It provides services, including design-assist, modularization, fabrication and erection of structural steel, heavy steel plate, trusses and girders, heavy equipment installation, as well as facility services for maintenance and shutdowns. The Life Sciences segment consists of Pansend Life Sciences, LLC, which is focused on supporting healthcare and biotechnology product development. The Spectrum segment holds a 25% interest in HC2 Broadcasting Holdings Inc., which operates broadcast television stations throughout the United States.

AI 分析 of Innovate Corp (VATE)

持有

Innovate Corp (VATE) is currently not a strong buy due to its low RSI of 24, indicating oversold conditions, and a current price of $5.38, which is significantly below its 52-week high of $21.30. However, the forward P/E ratio of 4.86 suggests potential value if the company can stabilize its earnings. The main risk is its recent performance, with a 20-day change of -27.69%, indicating ongoing volatility.

估值指標

Innovate Corp(VATE)目前預期本益比為 4.86,5 年平均預期本益比為 -1.23。

預期本益比

高估
5 年均值 P/E
-1.23
目前P/E
4.86
高估
1.94
低估
-4.41

預期 EV/EBITDA

嚴重低估
5 年均值 EV/EBITDA
41.92
目前EV/EBITDA
0.00
高估
47.04
低估
36.80

預期股價營收比

低估
5 年均值 P/S
0.12
目前P/S
0.00
高估
0.19
低估
0.04

事件時間軸

2026-08-10 (ET)

11:00:00

Innovate Trading Halted, Volatility Trading Pause

09:00:00

INNOVATE Corp. Files $100M Mixed Securities Shelf

08:30:00

IES Holdings to Acquire DBM Global for $650M

2026-02-02 (ET)

09:00:00

INNOVATE Announces DBM Global to Pay $5M Cash Dividend

2025-12-16 (ET)

08:10:00

INNOVATE Announces MediBeacon FDA Approval for Next-Gen TGFRTM System

資訊

VATE 常見問題 —— 由 Alphio AI 解答

Innovate Corp. is a diversified holding company. The Company has a portfolio of subsidiaries in a variety of operating segments. Its segments include Infrastructure (DBMG), Life Sciences (Pansend), and Spectrum. The DBMG segment consists of DBM Global Inc., which is a fully integrated construction company offering both construction and professional services primarily through its core subsidiaries. It provides services, including design-assist, modularization, fabrication and erection of structural steel, heavy steel plate, trusses and girders, heavy equipment installation, as well as facility services for maintenance and shutdowns. The Life Sciences segment consists of Pansend Life Sciences, LLC, which is focused on supporting healthcare and biotechnology product development. The Spectrum segment holds a 25% interest in HC2 Broadcasting Holdings Inc., which operates broadcast television stations throughout the United States. It operates in the Industrials sector (FABRICATED STRUCTURAL METAL PRODUCTS industry).

Innovate Corp (VATE) is currently not a strong buy due to its low RSI of 24, indicating oversold conditions, and a current price of $5.38, which is significantly below its 52-week high of $21.30. However, the forward P/E ratio of 4.86 suggests potential value if the company can stabilize its earnings. The main risk is its recent performance, with a 20-day change of -27.69%, indicating ongoing volatility.

暫無貼文

註冊或登入後參與討論

相關文章

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易